Success Metrics

Clinical Success Rate
80.0%

Based on 4 completed trials

Completion Rate
80%(4/5)
Active Trials
0(0%)
Results Posted
0%(0 trials)
Terminated
1(13%)

Phase Distribution

Ph not_applicable
7
88%
Ph phase_1
1
13%

Phase Distribution

1

Early Stage

0

Mid Stage

0

Late Stage

Phase Distribution8 total trials
Phase 1Safety & dosage
1(12.5%)
N/ANon-phased studies
7(87.5%)

Highest Phase Reached

Phase 1

Trial Status & Enrollment

Completion Rate

80.0%

4 of 5 finished

Non-Completion Rate

20.0%

1 ended early

Currently Active

0

trials recruiting

Total Trials

8

all time

Status Distribution
Active(1)
Completed(4)
Terminated(1)
Other(2)

Detailed Status

Completed4
unknown2
Terminated1
Not yet recruiting1

Development Timeline

Analytics

Development Status

Total Trials
8
Active
0
Success Rate
80.0%
Most Advanced
Phase 1

Trials by Phase

Phase 11 (12.5%)
N/A7 (87.5%)

Trials by Status

unknown225%
terminated113%
not_yet_recruiting113%
completed450%

Recent Activity

Clinical Trials (8)

Drug Details

Intervention Type
OTHER
Total Trials
8